The Uncertain Benefit of Adjuvant Chemotherapy in Advanced Low-Grade Serous Ovarian Cancer and the Pivotal Role of Surgical Cytoreduction

In our center, adjuvant chemotherapy is routinely offered in high-grade serous ovarian cancer (HGSOC) patients but less commonly as a standard treatment in low-grade serous ovarian cancer (LGSOC) patients. This study evaluates the efficacy of this paradigm by analysing survival outcomes and by compa...

Descripción completa

Detalles Bibliográficos
Autores principales: Johnson, Racheal Louise, Laios, Alexandros, Jackson, David, Nugent, David, Orsi, Nicolas Michel, Theophilou, Georgios, Thangavelu, Amudha, de Jong, Diederick
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8704009/
https://www.ncbi.nlm.nih.gov/pubmed/34945222
http://dx.doi.org/10.3390/jcm10245927

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8704009/
https://www.ncbi.nlm.nih.gov/pubmed/34945222
http://dx.doi.org/10.3390/jcm10245927

Ejemplares similares